Published in J Virol on April 01, 1998
Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. J Virol (2000) 5.26
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol (2001) 4.22
Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol (2002) 2.31
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol (1999) 1.98
Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol (1999) 1.93
Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol (2003) 1.93
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody. Liver Int (2008) 1.47
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J Virol (1999) 1.40
Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev (2000) 1.30
Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus. J Virol (2000) 1.24
Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models. J Infect Dis (2010) 1.21
Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol (2000) 1.18
Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis (2007) 1.09
Mouse models for the study of HCV infection and virus-host interactions. J Hepatol (2008) 1.05
Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J Immunol (2010) 1.04
Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection. J Virol (2005) 1.03
Liver immunology. Compr Physiol (2013) 0.99
Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees. Hepatology (2011) 0.97
Hepatitis C virus evasion mechanisms from neutralizing antibodies. Viruses (2011) 0.93
High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology (2007) 0.93
Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol (2001) 0.92
Evaluation of accumulation of hepatitis C virus mutations in a chronically infected chimpanzee: comparison of the core, E1, HVR1, and NS5b regions. J Virol (2001) 0.90
Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses. J Virol (2005) 0.85
Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome. Autoimmun Rev (2013) 0.84
Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections. Front Microbiol (2014) 0.80
Viral interactions with B-cells contribute to increased regulatory T-cells during chronic HCV infection. Viral Immunol (2011) 0.79
HCV animal models: a journey of more than 30 years. Viruses (2009) 0.78
Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees. World J Hepatol (2015) 0.78
Whole-blood hepatitis C virus RNA extraction methods. J Clin Microbiol (2001) 0.75
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92
Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol (1993) 8.47
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med (1989) 8.10
Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 7.33
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol (1992) 6.09
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79
Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol (1996) 4.59
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A (1992) 4.47
Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology (1991) 4.47
Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44
A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A (1993) 4.30
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet (1991) 3.97
Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) (1995) 3.85
Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A (1994) 3.76
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest (1995) 3.47
Structure of the 3' terminus of the hepatitis C virus genome. J Virol (1996) 3.40
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A (1993) 3.37
Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol (1993) 3.18
Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology (1996) 3.14
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02
National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology (1997) 2.89
Epidemiology of hepatitis C in the West. Semin Liver Dis (1995) 2.77
Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol (1993) 2.74
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med (1995) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol (1996) 2.47
A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol (1994) 2.35
Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology (1994) 2.33
Immunity in hepatitis C infection. J Infect Dis (1992) 2.28
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med (1991) 2.02
A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology (1993) 1.90
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
To C or not to C: these are the questions. Blood (1995) 1.70
Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res (1992) 1.68
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis (1996) 1.53
Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch Virol (1994) 1.52
Processing pathways of the hepatitis C virus proteins. J Hepatol (1996) 1.51
5' end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5' untranslated region. Virology (1992) 1.45
Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol (1992) 1.33
Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology (1995) 1.31
Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology (1994) 1.24
Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology (1992) 1.21
False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18
High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis (1993) 1.16
Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees. J Med Virol (1992) 1.16
Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J Virol (1996) 1.06
Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis (1997) 1.03
The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. J Infect Dis (1992) 1.01
Community prevalence of hepatitis C viraemia: a polymerase chain reaction study. J Med Virol (1994) 0.98
Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay. Dig Dis Sci (1996) 0.95
Expression of infectious viral particles by primary chimpanzee hepatocytes isolated during the acute phase of non-A, non-B hepatitis. J Infect Dis (1990) 0.91
Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region. J Infect Dis (1994) 0.91
Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products. Vox Sang (1997) 0.89
Detection of the hepatitis C virus genome in acute and chronic experimental infection in chimpanzees. J Clin Microbiol (1991) 0.83
Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitis. J Infect Dis (1993) 0.81
Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response. J Gen Virol (1992) 0.80
The biology of hepatitis C virus infection. Lessons learned from chimpanzees. Curr Stud Hematol Blood Transfus (1994) 0.78
Evaluation of a chimpanzee colony for antibodies to hepatitis C virus. J Med Virol (1991) 0.78
Absence of nonpercutaneous transmission of hepatitis C virus in a colony of chimpanzees. J Med Virol (1993) 0.77
Liver histology in anti-HCV-positive persons with normal or minimally elevated aminotransferases. J Clin Gastroenterol (1995) 0.77
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol (2001) 4.22
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol (2000) 3.26
The effects of variations in the number and sequence of targeting signals on nuclear uptake. J Cell Biol (1988) 2.89
Identification of four nuclear transport signal-binding proteins that interact with diverse transport signals. Mol Cell Biol (1989) 1.97
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology (2001) 1.94
Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc Natl Acad Sci U S A (1998) 1.90
Cloned hepatitis delta virus cDNA is infectious in the chimpanzee. J Virol (1989) 1.75
Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol (1993) 1.65
Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA. Virology (1993) 1.62
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J Virol (2001) 1.50
Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J Virol (1992) 1.45
Cyclic appearance of defective interfering particles of herpes simplex virus and the concomitant accumulation of early polypeptide VP175. Intervirology (1975) 1.40
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J Virol (1999) 1.40
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol (1980) 1.26
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24
Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus. J Virol (2000) 1.24
Tissue culture system for infection with human hepatitis delta virus. J Virol (1991) 1.21
Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses. J Virol (1984) 1.21
Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol (2000) 1.18
Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. Virology (1999) 1.18
Intracellular transport of SV40 large tumor antigen: a mutation which abolishes migration to the nucleus does not prevent association with the cell surface. Virology (1982) 1.17
Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J Virol (2001) 1.17
Infectious cDNA clone of the hepatitis C virus genotype 1 prototype sequence. J Gen Virol (2001) 1.16
Biochemical characterization of nuclear and cytoplasmic forms of SV40 tumor antigens encoded by parental and transport-detective mutant SV40-adenovirus 7 hybrid viruses. Virology (1980) 1.12
GB virus B as a model for hepatitis C virus. ILAR J (2001) 1.12
In vitro propagation and production of hepatitis E virus from in vivo-infected primary macaque hepatocytes. Virology (1996) 1.09
Clinical parameters of the normal baboons (Papio species) and chimpanzees (Pan troglodytes). Lab Anim Sci (1993) 1.09
Polyhedrin initiator codon altered to AUU yields unexpected fusion protein from a baculovirus vector. Biotechniques (1991) 1.05
Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses (1998) 1.05
Insertions within the hepatitis B virus capsid protein influence capsid formation and RNA encapsidation. J Virol (1995) 1.04
High level expression and phosphorylation of hepatitis B virus polymerase in insect cells with recombinant baculoviruses. Virology (1993) 1.03
Characterization of IM virus, which is frequently isolated from cerebrospinal fluid of patients with multiple sclerosis and other chronic diseases of the central nervous system. J Virol (1984) 1.02
Detection of simian virus 40 surface-associated large tumor antigen by enzyme-catalyzed radioiodination. Int J Cancer (1982) 1.01
In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes. Virology (1997) 1.01
Inhibition of nuclear migration of wild-type SV40 tumor antigen by a transport-defective mutant of SV40-adenovirus 7 hybrid virus. Virology (1980) 1.00
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Prevalence of serum antibodies against lymphocytic choriomeningitis virus in selected populations from two U.S. cities. J Med Virol (1992) 0.98
Structural comparisons of wild-type and nuclear transport-defective simian virus 40 large tumor antigens. Virology (1984) 0.98
Signal-mediated nuclear transport in simian virus 40-transformed cells is regulated by large tumor antigen. Proc Natl Acad Sci U S A (1992) 0.97
Interaction between hepatitis B virus core protein and reverse transcriptase. J Virol (2000) 0.95
CD8+ cells from HIV-2-infected baboons control HIV replication. AIDS (1997) 0.93
In vitro replication and expression of hepatitis B virus from chronically infected primary chimpanzee hepatocytes. Hepatology (1989) 0.92
Spontaneous amyloidosis in twelve chimpanzees, Pan troglodytes. J Med Primatol (2001) 0.92
Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice. Cancer Res (1984) 0.92
Expression of infectious viral particles by primary chimpanzee hepatocytes isolated during the acute phase of non-A, non-B hepatitis. J Infect Dis (1990) 0.91
Possible role of anti-idiotypic antibodies in the induction of tumor immunity. J Clin Invest (1987) 0.91
Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res (1993) 0.91
Molecular basis for "null" lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon. J Biol Chem (1994) 0.91
Isolation of an arenavirus from a marmoset with callitrichid hepatitis and its serologic association with disease. J Virol (1991) 0.89
Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein. J Virol (1999) 0.89
Molecular quantification of cell cycle-related gene expression at the protein level. Cytometry (2000) 0.88
Nuclear transport: a guide to import receptors. Trends Cell Biol (1992) 0.88
Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees. Hepatology (1999) 0.87
Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes. J Biol Chem (1994) 0.86
Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum. J Biol Chem (1997) 0.86
Eosinophilic bronchitis-like lesion as the cause of death in a Macaca mulatta: a first case report. J Med Primatol (2008) 0.84
The effects of SV40 large T antigen and p53 on nuclear transport capacity in BALB/c 3T3 cells. Exp Cell Res (1994) 0.84
Trisomy of chromosome 18 in the baboon (Papio hamadryas anubis). Cytogenet Genome Res (2006) 0.83
Age-related autoantibody production in a nonhuman primate model. Clin Exp Immunol (2001) 0.83
Effect of nuclear localization of large tumor antigen on growth potential of SV40-transformed cells. Virology (1981) 0.82
Biosynthesis and metabolism of lipoprotein (a). Curr Opin Lipidol (1995) 0.82
Replicative functions of the SV40(cT)-3 mutant defective for nuclear transport of T antigen. Virology (1985) 0.81
Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response. J Infect Dis (1997) 0.80
Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway. J Lipid Res (1999) 0.80
Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans. Arch Pathol Lab Med (1998) 0.80
High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression. Hum Gene Ther (2001) 0.80
Production of lipoprotein(a) by primary baboon hepatocytes. Biochim Biophys Acta (1989) 0.80
Immortalization of chimpanzee hepatocytes with an amphoteric retrovirus encoding simian virus 40 T antigen. Exp Cell Res (1992) 0.79
Mycobacterium tuberculosis-secreted protein antigens: immunogenicity in baboons. J Clin Immunol (2000) 0.78
Xenotransplantation. FASEB J (1994) 0.78
Induction of cellular DNA synthesis by a simian virus 40 mutant defective in nuclear transport of T antigen. Mol Cell Biol (1985) 0.78
Idiotype network components are involved in the murine immune response to simian virus 40 large tumor antigen. Cancer Immunol Immunother (1992) 0.77
Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells. Clin Exp Immunol (1993) 0.77
Intracellular processing of apo(a) in primary baboon hepatocytes. Chem Phys Lipids (1994) 0.76
Chlorpromazine, eosinophilia, and hepatotoxicity. Va Med (1979) 0.75
Experimental pneumonia virus of mice infection of guineapigs spontaneously infected with Bordetella bronchiseptica. Lab Anim (1997) 0.75
Genomic organization of the simian virus 40-adenovirus 7 hybrid virus, PARA(cT), that encodes a nuclear transport defective simian virus 40 T antigen. Virology (1986) 0.75
Interaction of human embryonal carcinoma cells and differentiated derivatives in vitro with simian virus 40, human adenovirus type 7, or PARA. Exp Cell Res (1990) 0.75
Genetic analysis of serum alanine transaminase activity in normal and hepatitis C virus-infected chimpanzees: an application of research-oriented genetic management. Lab Anim Sci (1996) 0.75
Immunogenicity of hepatitis B surface antigen derived from the baculovirus expression vector system: a mouse potency study. Biologicals (1991) 0.75
Susceptibility of peripheral blood mononuclear cells from gorillas, orangutans and baboons to diverse HIV isolates. AIDS (1996) 0.75